Literature DB >> 21464320

TNF-alpha-dependent loss of IKKbeta-deficient myeloid progenitors triggers a cytokine loop culminating in granulocytosis.

Arun K Mankan1, Ozge Canli, Sarah Schwitalla, Paul Ziegler, Jurg Tschopp, Thomas Korn, Florian R Greten.   

Abstract

Loss of IκB kinase (IKK) β-dependent NF-κB signaling in hematopoietic cells is associated with increased granulopoiesis. Here we identify a regulatory cytokine loop that causes neutrophilia in Ikkβ-deficient mice. TNF-α-dependent apoptosis of myeloid progenitor cells leads to the release of IL-1β, which promotes Th17 polarization of peripheral CD4(+) T cells. Although the elevation of IL-17 and the consecutive induction of granulocyte colony-stimulating factor compensate for the loss of myeloid progenitor cells, the facilitated induction of Th17 cells renders Ikkβ-deficient animals more susceptible to the development of experimental autoimmune encephalitis. These results unravel so far unanticipated direct and indirect functions for IKKβ in myeloid progenitor survival and maintenance of innate and Th17 immunity and raise concerns about long-term IKKβ inhibition in IL-17-mediated diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21464320      PMCID: PMC3080999          DOI: 10.1073/pnas.1018331108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  The IKK NF-kappa B system: a treasure trove for drug development.

Authors:  Michael Karin; Yumi Yamamoto; Q May Wang
Journal:  Nat Rev Drug Discov       Date:  2004-01       Impact factor: 84.694

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  Granulocyte colony-stimulating factor and its receptor.

Authors:  G D Demetri; J D Griffin
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

4.  Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17.

Authors:  Sudeepta Aggarwal; Nico Ghilardi; Ming-Hong Xie; Frederic J de Sauvage; Austin L Gurney
Journal:  J Biol Chem       Date:  2002-11-03       Impact factor: 5.157

5.  Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice.

Authors:  S B Forlow; J R Schurr; J K Kolls; G J Bagby; P O Schwarzenberger; K Ley
Journal:  Blood       Date:  2001-12-01       Impact factor: 22.113

6.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

Review 7.  NF-kappaB: linking inflammation and immunity to cancer development and progression.

Authors:  Michael Karin; Florian R Greten
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

8.  Interleukin-1 potentiates granulopoiesis and thrombopoiesis by producing hematopoietic factors in vivo.

Authors:  S Nakai; K Aihara; Y Hirai
Journal:  Life Sci       Date:  1989       Impact factor: 5.037

9.  IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis.

Authors:  U Senftleben; Z W Li; V Baud; M Karin
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

10.  IKK beta is required for peripheral B cell survival and proliferation.

Authors:  Zhi-Wei Li; Sidne A Omori; Tord Labuda; Michael Karin; Robert C Rickert
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

View more
  19 in total

1.  No major role for the transcription factor NF-κB in bone marrow function during peritonitis in the mouse.

Authors:  Eirunn Knudsen; Harald Carlsen; Arne Bøyum; Haakon Breien Benestad; Per Ole Iversen
Journal:  Int J Hematol       Date:  2014-05-24       Impact factor: 2.490

2.  Cell-selective inhibition of NF-κB signaling improves therapeutic index in a melanoma chemotherapy model.

Authors:  Thomas Enzler; Yasuyo Sano; Min-Kyung Choo; Howard B Cottam; Michael Karin; Hensin Tsao; Jin Mo Park
Journal:  Cancer Discov       Date:  2011-11       Impact factor: 39.397

3.  Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function.

Authors:  Sarah J Stein; Albert S Baldwin
Journal:  Blood       Date:  2013-05-13       Impact factor: 22.113

4.  Overexpression of NF-κB p65 in macrophages ameliorates atherosclerosis in apoE-knockout mice.

Authors:  Xin Ye; Xiaoting Jiang; Wei Guo; Katie Clark; Zhanguo Gao
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-10-08       Impact factor: 4.310

5.  Intestinal CCL11 and eosinophilic inflammation is regulated by myeloid cell-specific RelA/p65 in mice.

Authors:  Amanda Waddell; Richard Ahrens; Yi-Ting Tsai; Joseph D Sherrill; Lee A Denson; Kris A Steinbrecher; Simon P Hogan
Journal:  J Immunol       Date:  2013-04-05       Impact factor: 5.422

6.  Leukemia-Associated Nup214 Fusion Proteins Disturb the XPO1-Mediated Nuclear-Cytoplasmic Transport Pathway and Thereby the NF-κB Signaling Pathway.

Authors:  Shoko Saito; Sadik Cigdem; Mitsuru Okuwaki; Kyosuke Nagata
Journal:  Mol Cell Biol       Date:  2016-06-15       Impact factor: 4.272

Review 7.  Neutrophils in cancer: neutral no more.

Authors:  Seth B Coffelt; Max D Wellenstein; Karin E de Visser
Journal:  Nat Rev Cancer       Date:  2016-06-10       Impact factor: 60.716

8.  Non-Cell-Autonomous Activity of the Hemidesmosomal Protein BP180/Collagen XVII in Granulopoiesis in Humanized NC16A Mice.

Authors:  Lin Lin; Bin-Jin Hwang; Ning Li; Paul Googe; Luis A Diaz; Ed Miao; Barbara Vilen; Nancy E Thomas; Jenny Ting; Zhi Liu
Journal:  J Immunol       Date:  2020-09-30       Impact factor: 5.422

9.  Loss of IKKβ but Not NF-κB p65 Skews Differentiation towards Myeloid over Erythroid Commitment and Increases Myeloid Progenitor Self-Renewal and Functional Long-Term Hematopoietic Stem Cells.

Authors:  Jing Zhang; Li Li; Albert S Baldwin; Alan D Friedman; Ido Paz-Priel
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240

10.  Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in mice.

Authors:  Betty Lamothe; Yunju Lai; Lana Hur; Natalia Martin Orozco; Jing Wang; Alejandro D Campos; Min Xie; Michael D Schneider; Cynthia R Lockworth; Jared Jakacky; Diep Tran; Michael Ho; Sity Dawud; Chen Dong; Hui-Kuan Lin; Peter Hu; Zeev Estrov; Carlos E Bueso-Ramos; Bryant G Darnay
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.